Nephrology

Back to articles

Prevention of aminoglycoside-induced ototoxicity with N-acetylcysteine

KEY POINT

Oral administration of N-acetylcysteine 600 mg twice daily to patients on hemodialysis receiving gentamicin therapy lowers the incidence of aminoglycoside-induced ototoxicity, a recently published study concluded.